Back to Search Start Over

Psychometric Properties of the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa patient score (iscorEB-p): a patient-reported outcome measure.

Authors :
Salamon G
Strobl S
Field-Werners U
Diem A
Schwieger-Briel A
Pope E
Source :
The British journal of dermatology [Br J Dermatol] 2024 Jun 20; Vol. 191 (1), pp. 75-81.
Publication Year :
2024

Abstract

Background: In contrast to clinical diagnosis via external examination, patient-related outcome measures (PROMs) allow access to patients' internal perceptions. In the case of epidermolysis bullosa (EB) - a rare disease characterized by a wide variety of symptoms and individual disease courses - it is important to integrate the patient's perspective into diagnostic processes. The Instrument for Scoring Clinical Outcomes of Research for EB (iscorEB) is an EB-specific measurement tool, combining a clinician score (iscorEB-c) and a patient questionnaire (iscorEB-p).<br />Objectives: The aim of this study is to establish the iscorEB-p as an independent PROM tool by exploring its psychometric properties.<br />Methods: Sample-based psychometric testing and evaluation were performed on data collected via a multinational online cross-sectional study.<br />Results: Data analysis was performed with n = 95 participants across all EB types. The reliability and internal consistency of the iscorEB-p was excellent (α = 0.90). Principal component analysis with a varimax rotation resulted in a two-factor solution, explaining 55.6% of the total variance, with the distinct factors 'everyday life functioning' and 'specific EB symptoms'. Convergent validity was shown by high correlations to the Satisfaction With Life Scale (r = -0.52, P < 0.001), the Quality of Life in Epidermolysis Bullosa questionnaire (r = 0.72, P < 0.001) and the Epidermolysis Bullosa Family Burden of Disease questionnaire (r = -0.73, P < 0.001).<br />Conclusions: The iscorEB-p is a reliable and valid instrument to assess patient-reported health status of people with EB.<br />Competing Interests: Conflicts of interest The authors declare no conflicts of interest.<br /> (© The Author(s) 2024. Published by Oxford University Press on behalf of British Association of Dermatologists. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.)

Details

Language :
English
ISSN :
1365-2133
Volume :
191
Issue :
1
Database :
MEDLINE
Journal :
The British journal of dermatology
Publication Type :
Academic Journal
Accession number :
38261404
Full Text :
https://doi.org/10.1093/bjd/ljae019